ArticleInternational urology and nephrology2023

Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections.

S Nestler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.